Clinical Effectiveness Of Individualized Rare and Lesser-Known Homoeopathic Medicines in Lumbosacral Radiculopathy (Sciatica): A Prospective, Single-Blind Interventional Study Based on The Complete Repertory Approach

Abstract

Background: Lumbosacral radiculopathy (sciatica) is a debilitating neuro-orthopedic syndrome characterized by pain radiating along the sciatic nerve distribution, frequently accompanied by paresthesia, dural tension, and motor weakness. While routine homoeopathic prescribing relies heavily on a handful of well-known polychrests, clinical cases presenting with distinct anatomical laterality and uncommon postural or barometric modalities often require lesser-known ("rare") remedies indexed in comprehensive repertories.

Objectives: To evaluate the clinical effectiveness of individualized rare and lesser-known homoeopathic medicines—selected systematically via the Complete Repertory in CARA software—on radicular pain severity, back-specific functional disability, passive nerve-root mobility, motor strength, local tenderness, and rescue analgesic consumption over a 6-month follow-up period.

Methods: A prospective, single-blind, interventional clinical cohort study was conducted on 100 adult patients (aged 30–60 years; 53 females, 47 males) diagnosed with sciatica at the Outpatient Department of Ram Krishna College of Homoeopathy and Medical Sciences (RKCHMS), Bhopal, India. Prescriptions were individualized based on anatomical side affinity (63 right-sided, 37 left-sided), pain character, and modifying modalities using the Complete Repertory. Eleven remedies were allocated in descending order of clinical frequency: Phytolacca decandra (n = 16), Ruta graveolens (n = 14), Gnaphalium polycephalum (n = 13), Helonias dioica (n = 11), Ammonium muriaticum (n = 10), Kali bichromicum (n = 9), Ranunculus bulbosus (n = 8), Syphilinum (n = 7), Plumbum metallicum (n = 5), Dioscorea villosa (n = 4), and Tellurium metallicum (n = 3). Outcomes were evaluated at baseline and 6 months using the Visual Analogue Scale (VAS, 0–10), Maine–Seattle Back Questionnaire (MSBQ, 0–12), Weekly Rescue Analgesic Intake (pills/week), goniometric Straight Leg Raise (SLR) angle (degrees), Medical Research Council (MRC) Muscle Power (Grade 0–5), and Sciatic Tenderness (Grade 0–3).

Results: Across the entire cohort (N = 100), highly significant improvements (p < 0.001) were achieved across all six clinical parameters at 6 months: mean VAS pain dropped from 6.99 ± 1.24 to 3.24 ± 1.37 (Δ = 3.75 ± 1.71, Cohen’s d = 2.19), MSBQ functional disability declined from 8.52 ± 1.51 to 4.48 ± 1.58 (Δ = 4.04 ± 2.19, d = 1.84), and rescue analgesic intake fell by 82.2% from 7.77 ± 1.25 to 1.38 ± 1.00 pills/week (Δ = 6.39 ± 1.56, d = 4.10). Objectively, passive SLR excursion increased from 34.86° ± 8.06° to 62.12° ± 10.09° (Δ = +27.26° ± 12.49°, d = 2.18), motor power improved from 2.45 ± 0.96 to 2.97 ± 1.17 (Δ = +0.52 ± 0.67, d = 0.78), and tenderness decreased from 1.97 ± 0.64 to 1.66 ± 0.87 (Δ = 0.31 ± 0.63, d = 0.49). Subgroup analysis confirmed distinct therapeutic affinities: Kali bichromicum achieved the greatest pain reduction (VAS Δ = 4.89 ± 1.69, p < 0.001) and SLR gain (+32.89° ± 15.62°, p < 0.001); Gnaphalium polycephalum (+32.08°, p < 0.001) and Ruta graveolens (+29.93°, p < 0.001) markedly restored dural mobility and motor strength; and Dioscorea villosa (Δ = 5.75, p = 0.046), Plumbum metallicum (Δ = 5.00, p = 0.004), and Phytolacca decandra (Δ = 4.81, p < 0.001) produced the largest functional recovery on the MSBQ.

Conclusion: Individualized rare and lesser-known homoeopathic medicines selected via the Complete Repertory substantially reduce radicular pain and disability, restore passive neural mobility, and markedly curtail conventional analgesic dependence in patients with sciatica.